Inorganics 2018, 6(4), 123; https://doi.org/10.3390/inorganics6040123
Gold(III) Pyridine-Benzimidazole Complexes as Aquaglyceroporin Inhibitors and Antiproliferative Agents
Brech Aikman 1,†
, Margot N. Wenzel 1,†, Andreia F. Mósca 2,†, Andreia De Almeida 1,3, Wim T. Klooster 4, Simon J. Coles 4, Graça Soveral 2,* and Angela Casini 1,*
, Margot N. Wenzel 1,†, Andreia F. Mósca 2,†, Andreia De Almeida 1,3, Wim T. Klooster 4, Simon J. Coles 4, Graça Soveral 2,* and Angela Casini 1,*
1
School of Chemistry, Cardiff University, Main Building, Park Place, Cardiff CF10 3AT, UK
2
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal
3
Tumour MicroEnvironment Group, Division of Cancer and Genetics, School of Medicine, Cardiff University, Tenovus Building, Cardiff CF14 4XN, UK
4
School of Chemistry, University of Southampton, Southampton SO17 1BJ, UK
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Received: 11 October 2018 / Revised: 14 November 2018 / Accepted: 15 November 2018 / Published: 20 November 2018
(This article belongs to the Special Issue Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile)
Abstract
Gold compounds have been proven to be novel and versatile tools for biological applications, including as anticancer agents. Recently, we explored the potential of Au(III) complexes with bi-dentate N-donor ligands as inhibitors of the membrane water and glycerol channels aquaporins (AQPs), involved in different physiological and pathophysiological pathways. Here, eight new Au(III) complexes featuring a pyridine-benzimidazole scaffold have been synthesized and characterized via different methods. The stability of all the compounds in aqueous solution and their reactivity with glutathione have been investigated by UV–visible spectroscopy. The Au(III) compounds, tested for their AQPs inhibition properties in human Red Blood Cells (hRBC), are potent and selective inhibitors of AQP3. Furthermore, the compounds’ antiproliferative effects have been studied in a small panel of human cancer cells expressing AQP3. The complexes show only very moderate anticancer effects in vitro and are mostly active against the melanoma A375 cells, with marked expression of AQP3 at the level of the nuclear membrane. In general, the AQP3 inhibition properties of these complexes hold promises to develop them as chemical probes to study the function of this protein isoform in biological systems. View Full-TextKeywords:
Gold(III) complexes; pyridine benzimidazole; aquaporins; cancer; stopped-flow spectroscopy; antiproliferative activity
▼
Figures
Graphical abstract
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Aikman, B.; Wenzel, M.N.; Mósca, A.F.; De Almeida, A.; Klooster, W.T.; Coles, S.J.; Soveral, G.; Casini, A. Gold(III) Pyridine-Benzimidazole Complexes as Aquaglyceroporin Inhibitors and Antiproliferative Agents. Inorganics 2018, 6, 123.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Related Articles
Article Metrics
Comments
[Return to top]
Inorganics
EISSN 2304-6740
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert